16:20 EDT Clene (CLNN) files to sell 491,496 shares of common stock for holders
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLNN:
- Clene’s CNM-Au8 Shows Promise in Parkinson’s Treatment, Justifying Buy Rating
- Clene presents preclinical data supporting CNM-Au8 for Parkinson’s disease
- Clene price target lowered to $48 from $83 at Canaccord
- Clene Inc. Reports Q2 2025 Financial Results
- Optimistic Buy Rating for Clene Amidst Regulatory Progress and Strategic Milestones in ALS Treatment